Prosecution Insights
Last updated: October 25, 2026

Shanxi University

Technology areas: Biotechnology & Pharmaceuticals • Computing & Software • Communications

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Shanxi University currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are split among 3 distinct examiners and 3 distinct art units. The busiest examiner, EPSTEIN, TODD MATTHEW, is responsible for 1 pending office action, meaning each examiner in the portfolio is currently handling exactly one case. The use of 3 distinct art units for only 3 pending office actions indicates a high degree of technical variety in the university's biotechnology filings.

Practitioners should be prepared for three different prosecution environments, as each action is being reviewed by a different examiner in a different art unit. This lack of overlap means that a successful outcome or a specific argument used in one case may not have a direct influence on the other 3 pending office actions. The company's current strategy involves navigating 3 distinct sets of art unit guidelines and examiner expectations within the Biotechnology & Pharmaceuticals sector. With 3 distinct examiners involved, practitioners cannot rely on a single relationship to advance the portfolio. Instead, they must address the specific technical standards of each of the 3 distinct art units to resolve the 1 pending office action assigned to each examiner successfully.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
0
Medium (0%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (67%)
§112 only1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
1
Information Tech
33% of docket
1
Communications
33% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
EPSTEIN, TODD MATTHEW 1 60.8% +43.6%
NILSSON, ERIC 1 82.8% +16.8%
JONES, ANDREW B 1 71.7% +24.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19013153 Pseudomonas Putida omega-Transaminase Gene with Broad Substrate Spectrum and Application Thereof EPSTEIN, TODD MATTHEW —
18534295 MULTI-VIEW HYPERBOLIC-HYPERBOLIC GRAPH REPRESENTATION LEARNING METHOD NILSSON, ERIC —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19013153 Pseudomonas Putida omega-Transaminase Gene with Broad Substrate Spectrum and Application Thereof EPSTEIN, TODD MATTHEW —
18534295 MULTI-VIEW HYPERBOLIC-HYPERBOLIC GRAPH REPRESENTATION LEARNING METHOD NILSSON, ERIC —
18387862 GROUP INFORMATION GUIDED SMOOTH INDEPENDENT COMPONENT ANALYSIS METHOD FOR BRAIN FUNCTIONAL NETWORK ANALYSIS JONES, ANDREW B —

Top Art Units

Art UnitApps
1652 1
2151 1
2667 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19013153 Pseudomonas Putida omega-Transaminase Gene with Broad Substrate Spectrum and Application Thereof EPSTEIN, TODD MATTHEW 1652 §101§112 Non-Final OA — Pending Jan 08, 2025
18534295 MULTI-VIEW HYPERBOLIC-HYPERBOLIC GRAPH REPRESENTATION LEARNING METHOD NILSSON, ERIC 2151 §101§102§112 Non-Final OA — Pending Dec 08, 2023
18387862 GROUP INFORMATION GUIDED SMOOTH INDEPENDENT COMPONENT ANALYSIS METHOD FOR BRAIN FUNCTIONAL NETWORK ANALYSIS JONES, ANDREW B 2667 §112 Final Rejection — Pending Nov 08, 2023

Managing Shanxi University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Shanxi University have?

Shanxi University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Shanxi University applications?

Todd Matthew Epstein has the most, with 1 of Shanxi University's pending office actions.

What technology area are Shanxi University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month